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Abstract
Anterior cruciate ligament (ACL) ruptures are common injuries, specifically for young
athletes, and in order to repair this injury, the patients must undergo ACL reconstructive surgery.
This surgery commissions the use of autografts and allografts in order rebuild the torn ligament.
Traditional autografts are the patellar tendon autograft, which is the most common, and the
hamstring autograft. These grafts are made by transplanting tissue from the patellar tendon or the
hamstring to the ruptured ACL. Allografts are another type of graft that involves transplanting
tissue from a donor cadaver to the patient. Traditional autografts and allografts have been used
for years even though they have nagging side effects such as donor site morbidity, loss of muscle
strength, disease transmission, and graft rejection. However, now orthopedic doctors are looking
into tissue-engineered grafts in order to circumvent these problems.
Tissue-engineered grafts are made of synthetic material, such as collagen, and stem cells.
Theoretically, these grafts would not have the same problems that traditional autografts and
allografts have, but research has shown that tissue-engineered grafts have their own drawbacks
as well. The most glaring problem with tissue-engineered grafts is that they are not very durable,
so graft failure is a common side effect. Orthopedic doctors are working on ways to improve the
strength of tissue-engineered grafts, but these improvements have not been successfully tested on
humans yet. Therefore, as of today, tissue-engineered grafts are not recommended as a successful
alternative to traditional autografts and allografts.

3

The Future of ACL Reconstructive Surgery

Introduction
Anterior cruciate ligament (ACL) ruptures are a common injury in many young athletes,
and this type of injury causes players to miss an entire season of play. This injury and recovery
period is detrimental to players and their teams, so orthopedic doctors are actively searching for a
way to shorten recovery time, prevent reinjury, and find a better surgery method with fewer side
effects (Gobbi et al. 2006). The traditional method for treating ACL ruptures is to undergo ACL
reconstructive surgery using traditional autografts and allografts. Autograft transplants involve
transplanting tissue from one part of the patient’s body to the torn ACL. Usually, the tissue is
taken from the patellar tendon in the knee or from the hamstring, and both of these autografts
have proven to be effective in helping athletes recover from an ACL injury (Dhammi et al.
2015). Allograft transplants involve moving tissue from a donor cadaver to the patient’s torn
ACL, and this technique also helps athletes recover and return to play (Chang et al. 2003).
Traditional autografts and allografts have been used for years as treatment for ACL
injuries even though they have some major flaws, such as donor site morbidity or disease
transmission. However, new ACL grafts using ligament tissue engineering are being developed.
This new technique for creating grafts can possibly allow athletes to recover faster from ACL
injuries, and these grafts may also be able to lower the incidence of reinjury in patients
(Rathbone et al. 2012). This review will study literature detailing the advantages and drawbacks
of traditional autografts and allografts, and it will also review literature describing the advantages
and limitations of the new grafts being developed. Comparing the traditional autografts and
allografts to the newer tissue-engineered grafts will examine if the newer grafts will overall be
better than the traditional.
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Traditional Autografts and Allografts
When treating an ACL injury, orthopedic doctors usually recommend ACL reconstructive
surgery in order to stabilize the knee. This surgery involves replacing the torn ACL with another
ligament using either a patellar tendon autograft, a hamstring autograft, or an allograft from a
donor cadaver (Rathbone et al, 2012). These are the most popular grafts used, but they each have
their own side effects that make recovery difficult for patients.
Patellar Tendon Autograft (BPTB Graft)
The most recommended autograft is the patellar tendon autograft, and it is commonly
considered the “gold standard” of grafts (Dhammi et al. 2015). The patellar tendon autograft, or
the bone-patellar tendon-bone (BPTB) graft, is frequently chosen because when it has been
clinically tested, it has usually had great results. The article by Dhammi et al. (2015) showed that
83% of long-term patients receiving the BPTB graft now have normal knee function, and only
1.6% of patients needed additional surgery due to failure of the BPTB graft. 83% satisfaction is a
great statistic for many orthopedic doctors, but BPTB grafts also have their limitations.
Dhammi et al. (2015) also mentioned the disadvantages of the BPTB graft. Some common
side effects of this graft are patellar tendon ruptures, patellar/tibial fractures, quadricep weakness,
chronic anterior knee pain, difficulty kneeling, and numbness due to nerve damage during surgery.
Also, in the study by Gobbi & Francisco (2015), the authors found that after performing isokinetic
tests, which is a common test to determine strength of the muscles around the knee, the patients
receiving a BPTB graft had significantly decreased quadricep strength 3 months after surgery
compared to the other group of patients who received the hamstring autograft. This significant loss
of quadricep strength was also observed in by Hiemstra, Webber, Macdonald, & Kriellaars (2000).
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They found that subjects with the BPTB graft had decreased knee extension strength that was not
seen in the study group receiving the hamstring graft. Loss of knee strength is one of the main
reasons why it takes so long for athletes to recover from ACL injuries because they must take time
to rebuild their muscle strength. The BPTB graft seems to exacerbate this problem.
Hamstring Autografts
Although the bone-patellar tendon-bone graft is very popular, the hamstring autograft is
becoming a highly recommended alternative. The hamstring autograft usually involves
transplanting the semitendinosus tendon from the hamstring of the patient to replace the torn ACL,
or surgeons can also remove the gracilis tendon with the semitendinosus tendon, which is also
located in the hamstring (Dhammi et al. 2015). The main advantage the hamstring autograft has
over the BPTB graft is that chronic knee pain is greatly reduced after surgery. Hamstring autografts
also have a lower risk of failure compared to the common BPTB graft, and the quadricep muscle
is much stronger when the hamstring autograft is harvested (Hiemstra et al. 2000). However, the
hamstring autograft also has its drawbacks.
Dhammi et al. (2015) showed that some of the major disadvantages of the hamstring
autograft are greatly reduced knee flexion strength, sciatic nerve palsy, and inferior fixation
strength. Also, Clatworthy, Bulow & Bartlett (1999) found that there was significant tunnel
widening in patients receiving the semitendinosus and gracilis grafts, which was not found in
patients receiving the BPTB graft. Tunnel widening prevents the tendon from healing properly to
the bone, and it is also associated with anterior knee laxity. It has also been implicated as a major
cause for graft failure, which can lead to revision surgery to fix the failed hamstring graft (Srinivas,
Kanthila, Saya, & Vidyasagar, 2016). Hamstring autografts also result in decreased hamstring
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strength when compared to BPTB grafts 3 months after surgery (Gobbi &Francisco, 2015).
Therefore, even though hamstring grafts have many advantages compared to the BPTB grafts, they
are far from perfect.
Allografts
Autografts have been used and highly recommended for years, but their major disadvantage
is donor site morbidity, which is where the site of the extracted graft becomes weakened, stiff, and
sore. Allografts, on the other hand, do not have this side effect, which is why they are growing in
popularity. Allografts involve transplanting the patellar tendons, the hamstring tendons, and
Achilles tendons from a donor cadaver to a patient with a torn ACL (Dhammi et al. 2015). One of
the main advantages of allografts is that there is no harvest site damage because the tendon was
not removed from the patient. Surgery time is also shorter, and post-operative recovery is a lot
easier (Dhammi et al. 2015). In a study by Cole et al. (2005), the authors also found that ACL
reconstructive surgeries using allografts are much more cost efficient than surgeries involving
BPTB autografts. They averaged about $1,000 less than the ACL reconstructive surgeries using
patellar tendon autografts.
Allografts cost less money, and they offer a plethora of advantages not seen in patellar
tendon autografts and hamstring autografts. However, there are also some major disadvantages
when using allografts. The main limitations of allografts include disease transmission, delayed
graft incorporation, potential immune reactions, and tunnel widening (Chang et al. 2003). Disease
transmission is quite possibly the most dangerous disadvantage of allografts. HIV and hepatitis C
can possibly be transmitted to a healthy patient because of an allograft, and there have also been a
few documented cases of sepsis occurring after an allograft transplant (Chang et al. 2003). Also,
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since the allograft was removed from a cadaver, there is a chance that the tissue may be rejected
by the patient’s immune system (Dhammi et al. 2015). However, with new and advancing
knowledge about certain diseases and new rejection medicines, the risk of disease transmission
and graft rejection from an allograft is becoming less common. Still, it is a risk that makes many
patients hesitant to get allografts over patellar tendon autografts and hamstring autografts.
Summary
Patellar tendon autografts, hamstring autografts, and allografts from a donor cadaver have
been used for a long time. They each have certain advantages and disadvantages that make them
mostly equal when it comes to determining which graft works the best, although the patellar tendon
autograft is still the most highly recommended (Dhammi et al. 2015). However, orthopedic doctors
and surgeons are developing new alternatives to the traditional autografts and allografts. One of
these alternatives involve tissue ligament engineering, which could be the future of ACL
reconstructive surgery.
New Tissue-Engineered Grafts
Tissue-engineering combines science, engineering, and medicine in order to create cells
in vitro that can possibly grow and develop into a fully functioning tissue. Tissue-engineering
was originally industrialized to fix skin, cartilage, and bone damage, but now doctors are
considering it in order to produce a synthetic ACL (Rathbone et al. 2012). In order to produce a
functional tissue-engineered ACL, it is important to search for the right material that will mimic
the structure of a human ACL. Collagen has been extensively studied to create a synthetic ACL
(Vavken, Joshi, & Murray, 2009), and other prosthetic ACL’s have been developed using
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polytetrafluorethylene, polyester, and polypropylene ligament augmentation devices
(Patinharayil, 2017). However, the results from the use of these are not very promising.
Even though synthetic ACLs were tested on human subjects and failed in the late 1970s
and 1980s, they are still being studied closely as an alternative to traditional autografts and
allografts (Patinharayil, 2017). Technology has advanced since then, so better synthetic ACLs
are being developed. By using the appropriate cells, such as stem cells and primary fibroblasts,
and by finding the appropriate biomimetic scaffold to design the engineered ACL, it is possible
to make a functional tissue-engineered ACL (Yates et al. 2011). While these newly developed
synthetics have yet to be tested on humans, a bio-enhanced scaffold treated with platelet-rich
plasma was tested in animal ACLs, and there was significant improvement of mechanical and
biological healing of the ruptured ACL (Nau & Teuschl, 2015). Along with some successful
animal testing, Triton-X, a common detergent used in laboratories, was treated on ACL tissue,
and there was efficient decellularization of the tissue without major changes to the foundation of
the tissue. Decellularization could effectively prevent remodeling of the tissue-engineered ACL,
and it could also prevent tunnel widening and graft rejection so that the tissue-engineered ACLs
will be more functional in human subjects (Vavken et al.2009). Although there is more research
and testing to be done on tissue-engineered grafts, new developments in the study of tissueengineering could eventually yield a tissue-engineered ACL that could potentially rival the
traditional autografts and allografts. However, this does not necessarily mean that they will
overall be better than traditional grafts once they are tested on humans.
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Tissue-Engineered Grafts vs. Traditional Grafts
Although traditional autografts and allografts have been used for years, orthopedic
doctors are still actively searching for a better type of graft with fewer side effects for ACL
patients. As mentioned earlier, one of the main problems with traditional autografts is that they
can cause donor site morbidity (Rathbone et al. 2012). Allografts were an earlier alternative for
doctors that would remove the nagging problem of donor site morbidity since the ligament is
removed from a donor cadaver, but allografts have been known to transmit diseases from
cadavers to healthy patients, which is why many patients are hesitant to use them (Chang et al.
2003). In order to circumvent the problems of donor site morbidity, extended recovery periods,
and disease transmission, doctors are now looking into tissue-engineered grafts.
Possible Advantages of Tissue-Engineered Grafts
As previously stated, tissue ligament engineering is the creation of an artificial ACL
using synthetic materials and stem cells. The reason that this would be beneficial for ACL
reconstructive surgery is because the tissue would not be harvested from the patient, so donor
site morbidity can be avoided. Also, the tissue will be made of the patient’s own cells, so disease
transmission is not likely to occur (Patinharayil, 2017). Tissue-engineered grafts could
eventually be sturdier than traditional autografts and allografts, so recovery time after ACL
reconstructive surgery could be immensely shortened. Since tissue-engineered grafts could offer
a solution to many problems traditional grafts cause, many orthopedic doctors are very open to
using these grafts in the future when preforming ACL reconstructive surgery (Rathbone et al.
2012). Tissue-engineered grafts might sound great in theory, but there has yet to be a tissueengineered graft made that has tested successfully on humans.
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Disadvantages of Tissue-Engineered Grafts
In the 1970s and 1980s, some synthetic autografts were tested on humans. However,
these grafts were very unsuccessful. Almost 80% of these grafts failed in a few years mainly
because of wear and tear, tissue rejection, and mechanical problems (Patinharayil, 2017). This
failure was disheartening to many doctors, but some used what they learned to improve the
previously tested synthetics. Doctors looked to improve the synthetics by changing the materials
the synthetics were made of, by testing different types of cells to make the tissue, and by trying
to improve the mobility of these tissue-engineered ACL grafts (Yilgor et al. 2012). Even with
these changes, many orthopedic surgeons still found problems with tissue-engineered grafts.
These grafts are more susceptible to damage than the traditional autografts and allografts, and
they are not very long-lasting. Some patients who received tissue-engineered grafts reported
graft failures within the first year of using the improved grafts (Dhammi et al. 2015). Along with
reduced durability, tissue-engineered grafts could take three to six months to be made before
they can be harvested for surgery, while traditional autografts and allografts can be harvested
within days to weeks of the ACL injury (Patinharayil, 2017). Therefore, even if recovery time is
shortened because of decreased donor site morbidity, ACL patients would still have to wait an
unusually long time just to receive the graft they need for surgery.
Future Trends
Decreased durability and mobility, and the extended time it takes to form tissueengineered grafts are just a few of the major problems associated with artificial ACL grafts.
However, new models of tissue-engineered grafts, that have yet to be tested on humans, are
being created in order to combat some of these problems. As mentioned earlier, Triton-X is now
being used to decrease the graft rejection in patients receiving a tissue-engineered graft, and it
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can also prevent tunnel widening (Vavken et al.2009). The treatment of tissue-engineered grafts
using Triton-X could be the key to making these grafts more durable. Along with Triton-X,
orthopedic doctors are also working to develop a better scaffold, or a supportive structure, for the
tissue-engineered ACLs to be designed with. One design using a “braid-twist” scaffold is being
used to create an artificial ACL graft that is more identical to a patient’s actual ACL ligament
(Freeman et al. 2006). This upgrade in the design of tissue-engineered grafts could improve
mobility after the graft is implanted, make the graft more durable, and also potentially decrease
graft rejection.
Summary
Unfortunately, both of these improvements, the “braid-twist” design and the addition of
Triton-X, have not been tested on humans yet, so it is difficult to say whether this will ultimately
make tissue-engineered grafts the new “gold-standard” when it comes to ACL reconstructive
surgery. Therefore, since tissue-engineered grafts are still largely experimental and historically
unsuccessful, traditional autografts and allografts should be used and relied on for the time being.
Tissue-Engineered Autograft Implications for Athletes
One of the main reasons orthopedic doctors are more motivated to find an improved graft
is because many athletes suffer from ACL injuries. In fact, individuals who participate is sports
that involve jumping, pivoting, and cutting are at a much greater risk of rupturing their ACL than
non-athletes (Gobbi et al. 2006). Since young athletes are usually eager to return to play, they
must undergo ACL surgery to repair the torn ACL, which is usually a time-consuming and
grueling task.. Many young athletes deal with nagging soreness and decreased athletic ability
which can lead to depression because this extended recovery period causes them to miss out on
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doing something that they love (Tripp et al. 2007). In order to combat this problem, tissueengineered grafts are being investigated as an alternative to decrease recovery time for athletes.
Tendonitis and stiffness are common side effects of ACL surgeries when using traditional
autografts and allografts, and these problems can make it difficult for athletes to return to the
same level of play they had achieved before the ACL injury (Dhammi et al. 2015). Since these
problems have been theorized to be eliminated with tissue engineered grafts, many athletes and
doctors want to use these grafts for a better and faster recovery. However, even though donor site
morbidity is eliminated, other problems such as graft failure and durability keep tissueengineered grafts from being a better choice for athletes. Instead of athletes, many doctors are
now considering tissue-engineered grafts for elderly, less-active patients because tissueengineered grafts are easily worn-down and damaged (Patinharayil, 2017). Once the problem of
graft durability is solved in tissue-engineered grafts, then doctors may consider transitioning
them to athletes. Ultimately, if the major problems associated with tissue-engineered grafts are
resolved, then these grafts may potentially become the best option for athletes. However, until
that day comes, it is probably safest if athletes rely on traditional autografts and allografts when
dealing with an ACL injury.
Conclusion
Traditional autografts, such as the patellar tendon and hamstring grafts, and allografts are
commonly used in the repair of a ruptured ACL. They are fairly effective, but they also have
several side effects such as donor site morbidity, loss of muscle strength, disease transmission,
and graft rejection. In order to avoid these problems, orthopedic doctors considered using tissueengineered grafts, or grafts made of synthetic material and stem cells. Tissue-engineered grafts
would not cause problems like donor site morbidity or disease transmission, but they have other
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major flaws that keep them from currently being better than traditional autografts and allografts.
Tissue-engineered grafts take a while to be formed, and they are also less durable. Since these
grafts are frailer, they are more prone to failure. Presently, orthopedic doctors are working on
ways to improve tissue-engineered grafts so that they are sturdier, but these improvements have
yet to be tested on humans. While some doctors are optimistic, as of right now, it is impossible to
say whether tissue-engineered grafts are better than traditional autografts and allografts. Until the
major problems with tissue-engineered grafts are fixed and successfully tested, then ACL
patients, especially athletes, should stick to using traditional autografts and allografts.
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